Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could ...

THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines helped control the spread of the virus, the emergence of new variants continues ...

The NVIDIA BioNeMo platform provides state-of-the-art AI tools tailored for drug discovery. Its small molecule NIM ...

Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...

Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

For their part, Svensson and her colleagues have already filed patents on BRP, and she has co-founded a company that she hopes will develop the molecule for clinical use. No drug comes without ...

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...